Zavondemstat

(Synonyms: QC8222 free base; TACH 101 free base)
1 Cited Publications
Avis client

Based on 1 publication(s) in Google Scholar

Zavondemstat (QC8222 free base; TACH 101 free base) is an orally active pan-KDM4 and DHODH inhibitor. Zavondemstat inhibits KDM4A, KDM4B, KDM4C and KDM4D with IC50 values ≤0.080 µM, and exhibits an IC50 of 0.6 nM against human DHODH. Zavondemstat inhibits the KDM4C histone demethylase by competing with the α-ketoglutarate cofactor, and targets DHODH in de novo pyrimidine biosynthesis. Zavondemstat induces apoptosis and S-phase cell cycle arrest, reduces the tumor-initiating cell population, and shows broad antiproliferative activity across multiple cancer cell lines and donor-derived organoids. Zavondemstat can be used for research on colorectal cancer, esophageal squamous cell carcinoma, triple-negative breast cancer and glioblastoma.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté : 99.29%
  • CAS No.: 1851412-93-5
  • Formule: C26H29N3O3
  • Masse moléculaire:431.53
  • Stockage:

    4°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Zavondemstat

More

Voir tous les produits spécifiques à Isoform Histone Demethylase

More
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00